PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.\', \'Institute of Global Health, University of Siena, Siena, Brazil; Department of Paediatrics, University of Oxford, Oxford, UK.\', \'MRC Vaccines and Infectious Diseases Analytics Research Unit, Johannesburg, South Africa.\', \'Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil.\', \'Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK.\', \'Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa.\', \'Family Centre for Research with Ubuntu, Department of Paediatrics, University of Stellenbosch, Cape Town, South Africa.\', \'Soweto Clinical Trials Centre, Soweto, South Africa.\', \'Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.\', \'Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.\', \'Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK; Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.\', \'Division of Pulmonology, Groote Schuur Hospital and the University of Cape Town, South Africa; Faculty of Infectious and Tropical Diseases, Department of Immunology and Infection, London School of Hygiene & Tropical Medicine, London, UK.\', \'Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Translational and Clinical Research Institute, Immunity and Inflammation Theme, Newcastle University, Newcastle upon Tyne, UK.\', \'Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.\', \'NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.\', \'School of Population Health Sciences, University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.\', \'Department of Infection, Guy\'s and St Thomas\' NHS Foundation Trust, St Thomas\' Hospital, London, UK; MRC Clinical Trials Unit, University College London, London, UK.\', \'Clinical BioManufacturing Facility, University of Oxford, Oxford, UK.\', \'NIHR/Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.\', \'St George\'s Vaccine Institute, St George\'s, University of London, London, UK.\', \'AstraZeneca BioPharmaceuticals, Cambridge, UK.\', \'VIDA-Vaccines and Infectious Diseases Analytical Research Unit, Johannesburg, South Africa.\', \'Severn Pathology, North Bristol NHS Trust, Bristol, UK.\', \'NIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, London, UK.\', \'Department of Infection, Hull University Teaching Hospitals NHS Trust, UK.\', \'Escola Bahiana de Medicina e Saúde Pública, Salvador, Braziland Hospital São Rafael, Salvador, Brazil; Instituto D\'Or, Salvador, Brazil.\', \'Department of Infectious Diseases, Universidade Federal do Rio Grande do Norte, Natal, Brazil.\', \'London Northwest University Healthcare, Harrow, UK.\', \'Setshaba Research Centre, Pretoria, South Africa.\', \'Department of Internal Medicine, Hospital Quinta D\'Or, Rio de Janeiro, Brazil; Instituto D\'Or de Pesquisa e Ensino (IDOR), Rio de Janeiro, Brazil; Department of Internal Medicine, Universidade UNIGRANRIO, Rio de Janeiro, Brazil.\', \'NIHR Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, UK.\', \'Clinical Research Unit, Department of Clinical Medicine, Universidade Federal de Santa Maria, Santa Maria, Brazil.\', \'College of Medical, Veterinary & Life Sciences, Glasgow Dental Hospital & School, University of Glasgow, Glasgow, UK.\', \'Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Division of Infectious Diseases, Boston Children\'s Hospital, Boston, MA, USA.\', \'Infectious Diseases Service, Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.\', \'Clinical Infection Research Group, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK.\', \'MRC-University of Glasgow Centre for Virus Research & Department of Infectious Diseases, Queen Elizabeth University Hospital, Glasgow, UK.\', \'Department of Medicine, University of Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.\', \'Heart Lung Research Institute, Department of Medicine, University of Cambridge and Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.\', \'University of Nottingham and Nottingham University Hospitals NHS Trust, UK.\', \'Public Health Wales, Cardiff, Wales; Aneurin Bevan University Health Board, Newport, UK.\', \'Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: andrew.pollard@paediatrics.ox.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0140-6736(20)32661-110.1016/S0140-6736(20)32661-1
?:doi
?:hasPublicationType
?:journal
  • Lancet (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 33306989
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all